Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy

被引：0

作者：

Korb, M. ^{[1
]}

Peck, A. ^{[2
]}

Berger, K. ^{[3
]}

James, M. ^{[4
]}

Ghoshal, N. ^{[5
]}

Healzer, E. ^{[6
]}

Henchcliffe, C. ^{[1
]}

Khan, S. ^{[7
]}

Mammen, P. ^{[7
]}

Patel, S. ^{[8
]}

Pfeffer, G. ^{[9
]}

Ralston, S. ^{[10
]}

Roy, B. ^{[11
]}

Seeley, B. ^{[12
]}

Swenson, A. ^{[13
]}

Mozaffar, T. ^{[1
]}

Weihl, C. ^{[5
]}

Kimonis, V. ^{[1
]}

Alfano, L. ^{[14
]}

机构：

[1] UC Irvine Sch Med, Orange, CA USA

[2] Cure VCP Dis, Americus, GA USA

[3] NYU, Grossman Sch Med, New York, NY USA

[4] John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England

[5] Washington Univ, St Louis, MO 63110 USA

[6] Thriving Hope Consulting, Vinton, VA USA

[7] UT Southwestern Sch Med, Dallas, TX USA

[8] Wellness Sujata, Wadsworth, OH USA

[9] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada

[10] Univ Edinburgh, Edinburgh, Midlothian, Scotland

[11] Yale Sch Med, New Haven, CT USA

[12] Univ Calif San Francisco, San Francisco, CA 94143 USA

[13] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA

[14] Nationwide Childrens Hosp, Columbus, OH USA

来源：

NEUROMUSCULAR DISORDERS | 2021年 / 31卷

关键词：

D O I：

10.1016/j.nmd.2021.07.372

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EP.347

引用

页码：S155 / S156

页数：2

共 50 条

[21] Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy
Nalbandian, Angele
Khan, Arif A.
Srivastava, Ruchi
Llewellyn, Katrina J.
Tan, Baichang
Shukr, Nora
Fazli, Yasmin
Kimonis, Virginia E.
BenMohamed, Lbachir
INFLAMMATION, 2017, 40 (01) : 21 - 41
[22] Lysine Methylation of the Valosin-Containing Protein (VCP) Is Dispensable for Development and Survival of Mice
Fusser, Markus
Kernstock, Stefan
Aileni, Vinay Kumar
Egge-Jacobsen, Wolfgang
Falnes, Pal O.
Klungland, Arne
PLOS ONE, 2015, 10 (11):
[23] Valosin-containing protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy
Guinto, Jake B.
Ritson, Gillian P.
Taylor, J. Paul
Forman, Mark S.
ACTA NEUROPATHOLOGICA, 2007, 114 (01) : 55 - 61
[24] Frontotemporal dementia associated with a Valosin-Containing Protein mutation: report of three families
Spina, Salvatore
Van Laar, Amber D.
Murrell, Jill R.
de Courten-Myers, Gabrielle
Hamilton, Ronald L.
Farlow, Martin R.
Quinlan, John
DeKosky, Steven T.
Ghetti, Bernardino
FASEB JOURNAL, 2008, 22
[25] Valosin-containing protein mutation and Parkinson's disease
Chan, Nora
Le, Cindy
Shieh, Perry
Mozaffar, Tahseen
Khare, Manaswitha
Bronstein, Jeff
Kimonis, Virginia
PARKINSONISM & RELATED DISORDERS, 2012, 18 (01) : 107 - 109
[26] Regulation of Stress Granule Dynamicity by Valosin-Containing Protein
Moon, Strhanie
FASEB JOURNAL, 2022, 36
[27] Camptocormia in a Patient with Valosin-Containing Protein (VCP) Mutation
Fernandes-Filho, Jose Americo
Oskarsson, Bjorn
Thaisetthawatkul, Pariwat
McComb, Rodney
NEUROLOGY, 2013, 80
[28] Evolutionarily Conserved Functions for Valosin Containing Protein (VCP) in Cardiac and Skeletal Muscle Reveal Mechanistic Insights into Multisystem Proteinopathy
Brody, Matthew J.
Vanhoutte, Davy
Viswanathan, Meera C.
Tran Nguyen
Maillet, Marjorie
York, Allen J.
Sargent, Michelle A.
Cammarato, Anthony
Molkentin, Jeffery D.
CIRCULATION RESEARCH, 2018, 123
[29] Increased expression of valosin-containing protein in the skin of patients with amyotrophic lateral sclerosis
Ishikawa, Hiroaki
Yasui, Kanako
Oketa, Yoshihiko
Suzuki, Megumi
Ono, Seiitsu
JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (04) : 522 - 526
[30] Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma
Yamamoto, S
Tomita, Y
Hoshida, Y
Takiguchi, S
Fujiwara, Y
Yasuda, T
Yano, M
Nakamori, S
Sakon, M
Monden, M
Aozasa, K
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (13) : 2537 - 2544

← 1 2 3 4 5 →